Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-08-24 | 2022-08-11 |
| Drug Identification Number | 02469871 | 02469871 |
| Brand name | ADMELOG SOLOSTAR | ADMELOG SOLOSTAR |
| Common or Proper name | ADMELOG SOLOSTAR | ADMELOG SOLOSTAR |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | INSULIN LISPRO | INSULIN LISPRO |
| Strength(s) | 100UNIT | 100UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 5 pens/box | 5 pens/box |
| ATC code | A10AB | A10AB |
| ATC description | INSULINS AND ANALOGUES | INSULINS AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2022-08-26 | 2022-08-26 |
| Actual start date | 2022-08-24 | |
| Estimated end date | 2022-09-16 | 2022-09-16 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments |